Amount raised
$105M
Round
Series B
Date raised
November 11, 2026
Founded
2024
CompanyNeurosterix
IndustryBiotechnology
LocationGeneva, Switzerland
InvestorsRTW Investments
Websiteneurosterix.com
Founder
Get new raises like this every week
Free weekly list of newly funded startups and their founders.
About Neurosterix
a clinical-stage biotechnology company focused on transforming neuropsychiatric care through selective allosteric modulation
- How much did Neurosterix raise?
- Neurosterix raised $105M in a Series B round on November 11, 2026. Investors include RTW Investments.
- Who founded Neurosterix?
- Fred Callori founded Neurosterix in 2024.
- Where is Neurosterix based?
- Neurosterix is based in Geneva, Switzerland.